News Search Results
Oct 16, 2025, 13:57 ET Alamar Biosciences poszerza skład zespołu zarządczego, aby przejść na kolejny etap rozwoju
doświadczenia w zakresie zarządzania operacyjnego i finansowego w różnych sektorach i odegrał kluczową rolę w procesie wprowadzenia spółki 10x Genomics na giełdę w 2019 r., pełniąc funkcję dyrektora finansowego przez ponad pięć lat. Wcześniej przez ponad trzy lata był wiceprezesem ds. finansów
More news about: Alamar Biosciences, Inc.
Oct 16, 2025, 13:55 ET Alamar Biosciences rozšiřuje výkonné vedení pro další fázi růstu
než 25 let zkušeností s provozním a finančním vedením v různých odvětvích, působil mimo jiné více než pět let jako finanční ředitel společnosti 10x Genomics a v roce 2019 sehrál klíčovou roli při jejím vstupu na burzu. Přes 3 roky také působil na postu viceprezidenta pro globální finance a provoz ve
More news about: Alamar Biosciences, Inc.
Oct 15, 2025, 09:12 ET Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth
Financial Officer. Justin brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Justin served for over 3 years as Tesla's VP of Worldwide Finance and Operations, supporting
More news about: Alamar Biosciences, Inc.
Oct 15, 2025, 09:12 ET Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth
Financial Officer. Justin brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Justin served for over 3 years as Tesla's VP of Worldwide Finance and Operations, supporting
More news about: Alamar Biosciences, Inc.
Oct 09, 2025, 16:05 ET 10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
archived and available for replay for at least 45 days after the event. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health.
More news about: 10x Genomics, Inc.
Sep 17, 2025, 11:48 ET Precision Cell Systems Completes Two Acquisitions to Consolidate Best-in-Class Technologies Serving 700+ Customers for Cell Analysis
industry veterans with proven track records. CEO Anup Parikh previously held leadership roles at Mission Bio and 10X Genomics. He is joined by Chief Commercial Officer Terry Salyer, who drove revenue growth at Unchained Labs and ProteinSimple,
More news about: Precision Cell Systems